NYSE - Nasdaq Real Time Price
USD
CVS Health Corporation (CVS)
104.72
-0.09
(-0.09%)
At close: July 2 at 4:00:02 PM EDT
104.52
-0.21
(-0.20%)
After hours: July 2 at 7:57:14 PM EDT
Trade CVS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for CVS
Chart does not reflect overnight price.
- Previous Close
104.81 - Open
104.58 - Bid 104.13 x 10000
- Ask 104.85 x 10000
- Day's Range
103.22 - 105.23 - 52 Week Range
58.50 - 106.15 - Volume
5,506,614 - Avg. Volume
8,335,361 - Market Cap (intraday)
133.615B - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
45.93 - EPS (TTM)
2.28 - Earnings Date (est.) Jul 30, 2026
- Forward Dividend & Yield 2.66 (2.54%)
- Ex-Dividend Date Apr 23, 2026
- 1y Target Est
105.69
Recent News
View More
Performance Overview
Trailing total returns as of 7/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CVS
34.21%
S&P 500 (^GSPC)
9.32%
1-Year Return
CVS
62.99%
S&P 500 (^GSPC)
20.17%
3-Year Return
CVS
70.20%
S&P 500 (^GSPC)
68.15%
5-Year Return
CVS
49.94%
S&P 500 (^GSPC)
71.94%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 7/1/2026
-
Market Cap
133.73B
-
Enterprise Value
200.27B
-
Trailing P/E
45.97
-
Forward P/E
14.22
-
PEG Ratio (5yr expected)
0.29
-
Price/Sales (ttm)
0.33
-
Price/Book (mrq)
1.73
-
Enterprise Value/Revenue
0.49
-
Enterprise Value/EBITDA
17.99
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.72%
-
Return on Assets (ttm)
2.67%
-
Return on Equity (ttm)
3.75%
-
Revenue (ttm)
405.62B
-
Net Income Avi to Common (ttm)
2.93B
-
Diluted EPS (ttm)
2.28
Balance Sheet and Cash Flow
-
Total Cash (mrq)
11.8B
-
Total Debt/Equity (mrq)
100.91%
-
Levered Free Cash Flow (ttm)
5.2B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
CVS Health Corp. employs roughly 300,000 people and operates around 9,000 community destinations, more than 2,000 medical clinics, and a PBM with approximately 90 million plan members and expanding specialty pharmacy solutions. CVS also serves more than 25 million people through traditional, voluntary, and consumer-directed health insurance products and related services. In total, it engages with more than 185 million consumers each year. Aetna was acquired at the end of 2018. The corporate headquarters is in Woonsocket, Rhode Island.
CVS Health Corp. employs roughly 300,000 people and operates around 9,000 community destinations, more than 2,000 medical clinics, and a PBM with approximately 90 million plan members and expanding specialty pharmacy solutions. CVS also serves more than 25 million people through traditional, voluntary, and consumer-directed health insurance products and related services. In total, it engages with more than 185 million consumers each year. Aetna was acquired at the end of 2018. The corporate headquarters is in Woonsocket, Rhode Island.
RatingPrice Target -
The major indices are mixed at midday on Wednesday. Inflation on the wholesale side is rising faster than expected. Headline PPI came in at 6.0% for April, well above the 4.3% pace the month prior. Core PPI was 4.4% for April, also well above the 3.7% rate the month prior. Today's data follows a bump in CPI yesterday. Gas prices at the pump have been rising as well. Crude oil is back up to $104 per barrel. The yield on the 10-year note is 4.49%, and the VIX volatility index is at 18.
The major indices are mixed at midday on Wednesday. Inflation on the wholesale side is rising faster than expected. Headline PPI came in at 6.0% for April, well above the 4.3% pace the month prior. Core PPI was 4.4% for April, also well above the 3.7% rate the month prior. Today's data follows a bump in CPI yesterday. Gas prices at the pump have been rising as well. Crude oil is back up to $104 per barrel. The yield on the 10-year note is 4.49%, and the VIX volatility index is at 18.
-
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Value stocks -- a market segment that includes high-yield stocks -- outperformed growth stocks in 2022. In 2025, value stocks and growth stocks had similar returns, with growth advancing 13.8% and value returning 13.6%. That's a recent rarity, as for the past decade-plus, the performance record has favored growth. But in 2022, the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks), and value stocks outpaced growth stocks that year. While growth stocks led for a few years after that, value stocks are back in the picture as investors rotate out of higher-priced AI growth stocks in search of more reasonable valuations. Value stocks tend to be more resilient in times of market uncertainty and higher volatility as they are less likely to overreact to economic news. In any event, the value sector is the place to achieve income.
Value stocks -- a market segment that includes high-yield stocks -- outperformed growth stocks in 2022. In 2025, value stocks and growth stocks had similar returns, with growth advancing 13.8% and value returning 13.6%. That's a recent rarity, as for the past decade-plus, the performance record has favored growth. But in 2022, the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks), and value stocks outpaced growth stocks that year. While growth stocks led for a few years after that, value stocks are back in the picture as investors rotate out of higher-priced AI growth stocks in search of more reasonable valuations. Value stocks tend to be more resilient in times of market uncertainty and higher volatility as they are less likely to overreact to economic news. In any event, the value sector is the place to achieve income.
